| Literature DB >> 27313755 |
Chen Huang1, Guimin Zhao1, Lianjing Wang1, Huichao Zhang2, Xiaolin Wu1, Mingzeng Zhang1, Ruijuan Ma1, Ling Wang1, Yueping Liu3, Lihong Liu1.
Abstract
Hodgkin's lymphoma (HL) is a type of hematological neoplasm that generally appears alone, with a low incidence. The majority of cases histopathologically present as B-cell lymphoma. Multiple myeloma (MM) is defined as the neoplastic proliferation of a single clone of plasma cells producing a monoclonal immunoglobulin (Ig). The coexistence of HL and MM is rare, however, the present study reports such a case. On May 31, 2012, a 45-year-old man was diagnosed with HL, stage III, 31 months ago. At the same time, computed tomography and magnetic resonance imaging showed osteolytic lesions, a significant increase in IgA λ chains, and multiple myeloma cells on bone marrow aspiration. Following 8 cycles of chemotherapy, the patient received maintenance treatment with thalidomide and dexamethasone. During 2 years of follow-up, the patient has maintained a complete response for HL and a stable disease state for MM. The coexistence of HL and MM is rare. Further study of such cases may explain the associations between these two tumors and aid the production of effective treatment options.Entities:
Keywords: Hodgkin's lymphoma; disease diagnosis; multiple myeloma
Year: 2016 PMID: 27313755 PMCID: PMC4888288 DOI: 10.3892/ol.2016.4503
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967